Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients
Creighton Authors
Zhao, Yingchun
Zhao, Yingchun
Admin. Units
School of Medicine; Department of Medicine; Endocrinology; Osteoporosis
School of Medicine; Department of Medicine; Endocrinology; Osteoporosis
Title
Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients
Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients
Authors
Xu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B.; Ma, R.; Yuan, R.; Zhou, H.; Liu, Z.
Xu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B.; Ma, R.; Yuan, R.; Zhou, H.; Liu, Z.
Journal
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology
Volume
75
Issue
2
Pages
522-534
75
Issue
2
Pages
522-534
Date
2013, February
2013, February
Metadata
Show full item record
Link
Check for Full-Text (may not be available)
Check for Full-Text (may not be available)
Citation
Xu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B., et al. (2013). Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients. Br J Clin Pharmacol, February 2013, 75(2):522-534. doi: http://dx.doi.org/10.1111/j.1365-2125.2012.04379.x
Xu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B., et al. (2013). Association between eIF3α Polymorphism and Severe Toxicity Caused by Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients. Br J Clin Pharmacol, February 2013, 75(2):522-534. doi: http://dx.doi.org/10.1111/j.1365-2125.2012.04379.x